AGI Dermatic s a biotechnology company specializing in DNA skin repair and photobiology claims to be working on a DNA damage-control product thus far is called Dimericine Currently in stage-three clinical trials.
Dimericine, the company claims to contain, a customized enzyme that can recognize DNA damage caused by ultraviolet light and speed up repair
“We call it a morning-after lotion. It can be used after sun exposure but before damage has arrived. says the president of the company
Filed under: DNA medicine, DNA therapeutics, Genomics, bioinformatics blog, genetics, microarray blog
AGI Dermatic s a biotechnology company specializing in DNA skin repair and photobiology claims to be working on a DNA damage-control product thus far is called Dimericine Currently in stage-three clinical trials.
Dimericine, the company claims to contain, a customized enzyme that can recognize DNA damage caused by ultraviolet light and speed up repair
“We call it a morning-after lotion. It can be used after sun exposure but before damage has arrived. says the president of the company
Filed under: DNA medicine, DNA therapeutics, Genomics, bioinformatics blog, genetics, microarray blog